Mainz Biomed (QUCY) investor relations material

Company overview and business model

• Focuses on developing intelligent, scalable platforms integrating AI and quantum computing for next-generation control systems in unmanned, aerial, and underwater vehicles, including drones and robotic fleets.

• Aims to address limitations of classical computing in autonomous vehicle control by enabling real-time, high-dimensional, multi-objective optimization.

• Targets applications in defense, commercial logistics, disaster response, and critical infrastructure operations.

• Operates as a Dutch public company with a U.S. subsidiary, Quantum Drones Corporation, and principal offices in West Palm Beach, Florida.

• Recently changed its name from Mainz Biomed N.V. to Quantum Cyber N.V. in April 2026.

Financial performance and metrics

• As of June 2, 2026, the public float was $78,524,586, based on 22,767,254 ordinary shares outstanding and a last reported sale price of $3.56 per share on May 21, 2026.

• Ordinary shares are listed on Nasdaq Capital Market under the symbol “QUCY.”

Use of proceeds and capital allocation

• Net proceeds from securities sales are intended for general corporate purposes, including working capital and capital expenditures.

• More detailed allocation and milestones will be provided in applicable prospectus supplements.